Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Biomaterial developments for bone tissue engineering.

K J Burg1, S Porter, J F Kellam

  • 1Department of Bioengineering, Clemson University, SC 29634-0905, USA.

Biomaterials
|October 31, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Oral health care pathways for patients with epidermolysis bullosa: A position statement from the European reference network for rare skin diseases.

Journal of the European Academy of Dermatology and Venereology : JEADV·2024
Same author

Plethora of drugs.

British dental journal·2022
Same author

Quantitative CT analysis using functional imaging is superior in describing disease progression in idiopathic pulmonary fibrosis compared to forced vital capacity.

Respiratory research·2018
Same author

Chikungunya fever: General and oral healthcare implications.

Oral diseases·2018
Same author

Establishing a clinical phenotype for cachexia in end stage kidney disease - study protocol.

BMC nephrology·2018
Same author

Changes in brain-behavior relationships following a 3-month pilot cognitive intervention program for adults with traumatic brain injury.

Heliyon·2017
Same journal

Corrigendum to "Photodynamic therapy produces enhanced efficacy of antitumor immunotherapy by simultaneously inducing intratumoral release of sorafenib" [Biomaterials 2020, 240, 119845].

Biomaterials·2026
Same journal

Mg-integrated octopus-inspired hydrogel dressing enables autonomous adhesion and wound closure for enhanced healing via sequential microenvironment regulation.

Biomaterials·2026
Same journal

Engineering miRNA-223 nanocomplexes via bioorthogonal self-assembly for precision therapy of intervertebral disc degeneration.

Biomaterials·2026
Same journal

Corrigendum to "Enhanced fluorescence imaging guided photodynamic therapy of sinoporphyrin sodium loaded graphene oxide" [Biomaterials 42 (2015) 16442].

Biomaterials·2026
Same journal

An injectable Ce-MnCo LDH nanozyme gel with cascade catalytic activity for acute radiation proctitis in rats.

Biomaterials·2026
Same journal

Peptide coacervate-mediated siRNA delivery for dual PD-1/PD-L1 blockade to enhance colorectal cancer immunotherapy.

Biomaterials·2026
See all related articles

Bone tissue engineering advances require integrating clinical needs with materials science for effective bone graft alternatives. This review highlights biomaterials, osseoactive factors, and design features for clinically relevant engineered bone devices.

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Orthopedic Surgery

Background:

  • Bone grafting is a common surgical procedure with limitations.
  • Current bone graft materials face challenges in efficacy and availability.
  • Advancements in materials technology are crucial for developing improved bone tissue engineering solutions.

Purpose of the Study:

  • To review the clinical need for bone tissue-engineered alternatives to current bone grafting materials.
  • To provide a status report on available bone tissue-engineering devices.
  • To discuss recent progress in biomaterials research for bone regeneration.

Main Methods:

  • Literature review of clinical needs and materials science in bone tissue engineering.
  • Analysis of current bone tissue-engineering devices and biomaterials research.

Related Experiment Videos

  • Examination of osseoactive factor delivery systems using bioceramics and biopolymers.

    • Main Results:

    • Identified a significant clinical demand for advanced bone graft substitutes.
    • Assessed the current landscape of clinically available bone tissue-engineering devices.
    • Highlighted recent breakthroughs in biomaterials, including osseoactive factors and delivery methods.

    Conclusions:

    • Integrating clinical requirements with materials science is essential for successful bone tissue engineering.
    • Bioceramics and absorbable biopolymers show promise for delivering osseoactive factors.
    • Further research into desirable design features will enhance the clinical effectiveness of engineered bone devices.